Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527130) titled 'C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome' on April 7.

Study Type: Observational

Primary Sponsor: Mayo Clinic

Condition: COVID-19

Intervention: Drug: C11 ER176 Tracer

Recruitment Status: Not recruiting

Date of First Enrollment: May 2026

Target Sample Size: 10

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07527130

Published by HT Digital Content Services with permission from Health Daily Digest....